Why the study?
Does streptokinase infusion induce a proliferative response of peripheral blood mononuclear cells in patients with and without acute myocardial infarction?
Does streptokinase infusion induce a proliferative response of peripheral blood mononuclear cells in patients with and without acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Streptokinase infusion induces a detectable in vitro proliferative response of peripheral blood mononuclear cells, primarily CD-2 positive cells, within five days to five weeks.
In vitro proliferative PBM responses were investigated for 26 patients with and 5 patients without acute myocardial infarction. All patients were initially treated with streptokinase (1.5 MIU infused for 1 hour). Five weeks after the disease increased responses to streptokinase, PPD and PHA were seen; but only for streptokinase had original nonresponders become responders (7 out of 14 nonresponders). The increased responsiveness to streptokinase could be detected five days after antigen infusion, and CD-2 positive cells constituted a major part of the proliferating PBM population. The responses after antigen infusion varied within a wide range both for patients with and without myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Øystein Bruserud (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: